HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications.

AbstractPURPOSE:
Transurethral resection of the prostate (TURP) is still the gold standard for the surgical treatment of symptomatic benign prostatic hyperplasia. However, the associated morbidity and blood loss remain concerns. A coagulating intermittent cutting (CIC) device with constant voltage pulses and controlled pulse intervals was recently developed. The impact of CIC on bleeding and blood transfusion rates as well as the occurrence of the TUR syndrome were investigated.
MATERIALS AND METHODS:
From January 2000 to July 2002, 271 consecutive patients with symptomatic benign prostatic hyperplasia underwent TURP with the CIC device. In addition to blood transfusion rates, serum hemoglobin and electrolytes were determined in all patients immediately before and after TURP.
RESULTS:
The mortality rate in the 271 patients subjected to TURP was 0.0%. Mean decrease in hemoglobin after TURP was 1.08 mg/dl. Intraoperative and postoperative blood transfusions were required in 7 patients (2.6%), and clinical signs of the transurethral resection syndrome were noted in 1.1% of patients.
CONCLUSIONS:
Coagulating intermittent cutting dramatically improves the safety of TURP by decreasing intraoperative and postoperative blood loss, and the rate of blood transfusions. With this blood sparing device we anticipate a lower incidence of hemostatic complications from TURP.
AuthorsAndreas P Berger, Walter Wirtenberger, Jasmin Bektic, Hannes Steiner, Robert Spranger, Georg Bartsch, Wolfgang Horninger
JournalThe Journal of urology (J Urol) Vol. 171 Issue 1 Pg. 289-91 (Jan 2004) ISSN: 0022-5347 [Print] United States
PMID14665896 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Loss, Surgical (prevention & control, statistics & numerical data)
  • Blood Transfusion (statistics & numerical data)
  • Hemostasis, Surgical (methods)
  • Humans
  • Male
  • Middle Aged
  • Prostatic Hyperplasia (surgery)
  • Retrospective Studies
  • Transurethral Resection of Prostate (adverse effects, methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: